Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia-Reference-Cited by-同舟云学术

Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia

Published:2019-02-22 Issue:3 Volume:36 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Alves Raquel,Gonçalves Ana Cristina,Jorge Joana,Alves Joana,Alves da Silva António,Freitas-Tavares Paulo,Nascimento Costa José M.,Almeida António M.,Sarmento-Ribeiro Ana B.^ORCID

Funder

Fundação para a Ciência e a Tecnologia

Center of Investigation on Environment, Genetics and Oncobiology

FEDER through the Operational Program Competitiveness Factors – COMPETE and FCT

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s12032-019-1253-5/fulltext.html

Reference35 articles.

1. Ali MAM. Chronic myeloid leukemia in the era of tyrosine kinase inhibitors: an evolving paradigm of molecularly targeted therapy. Mol Diagn Therapy. 2016;20(4):315–33. https://doi.org/10.1007/s40291-016-0208-1 .

2. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring. Am J Hematol. 2016;91:252–65. https://doi.org/10.1002/ajh.24275 .

3. Frazer R, Irvine AE, McMullin MF. Chronic myeloid leukaemia in the 21st century. Ulster Med J. 2007;76(1):8–17.

4. Quentmeier H, Eberth S, Romani J, Zaborski M, Drexler HG. BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance. J Hematol Oncol. 2011;4(1):6. https://doi.org/10.1186/1756-8722-4-6 .

5. Alves R, Fonseca AR, Gonçalves AC, Ferreira-Teixeira M, Lima J, Abrantes AM, et al. Drug transporters play a key role in the complex process of Imatinib resistance in vitro. Leuk Res. 2015;39(3):355–60. https://doi.org/10.1016/j.leukres.2014.12.008 .

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the antitumor mechanism of 7α-acetoxy-6β-hydroxyroyleanone from Plectranthus hadiensis in glioblastoma;Journal of Ethnopharmacology;2024-12

2. Transcriptome- and metabolome-based candidate mechanism of BCR-ABL-independent resistance to olverembatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia;Functional & Integrative Genomics;2023-01-31

3. Alvespimycin Inhibits Heat Shock Protein 90 and Overcomes Imatinib Resistance in Chronic Myeloid Leukemia Cell Lines;Molecules;2023-01-26

4. Targeting N-cadherin (CDH2) and the malignant bone marrow microenvironment in acute leukaemia;Expert Reviews in Molecular Medicine;2023

5. Agaricus blazei extract FA2bβ enhances the sensitivity of K562/ADR cells through the PI3K/Akt/mTOR signalling pathway;2022-12-12